Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia

OBJECTIVE: The development of both type I and type II diabetes after initiation of some atypical neuroleptics has been reported, primarily in studies involving small series of patients. This study used administrative data from a large national sample of patients with a diagnosis of schizophrenia to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of psychiatry 2002-04, Vol.159 (4), p.561-566
Hauptverfasser:	Sernyak, Michael J., Leslie, Douglas L., Alarcon, Renato D., Losonczy, Miklos F., Rosenheck, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adverse Drug Reaction Reporting Systems Aged Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Antipsychotic drugs Benzodiazepines Biological and medical sciences Clozapine - adverse effects Clozapine - therapeutic use Diabetes Diabetes Mellitus, Type 1 - chemically induced Diabetes Mellitus, Type 1 - diagnosis Diabetes Mellitus, Type 2 - chemically induced Diabetes Mellitus, Type 2 - diagnosis Dibenzothiazepines - adverse effects Dibenzothiazepines - therapeutic use Drug therapy Drug toxicity and drugs side effects treatment Female Humans Male Medical sciences Middle Aged Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Pirenzepine - adverse effects Pirenzepine - analogs & derivatives Pirenzepine - therapeutic use Quetiapine Fumarate Regression Analysis Risk Factors Risperidone - adverse effects Risperidone - therapeutic use Schizophrenia Schizophrenia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!